Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2 vs 5 Days Octreotide for Variceal Rebleed
NCT05199038Phase 4Unknown
- Sponsor
- Tanta University
- Start
- Jun 2022
- Primary completion
- Jun 2023
- Modality
- Peptides
01
Overview
A Phase 4 trial of Octreotide long-acting injection in esophageal varices, sponsored by Tanta University. Status: unknown.
02
Drugs
Octreotide long-acting injection
03
Conditions
esophageal varices
Beyond the preview
Go deeper on NCT05199038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05199038.